Efficacy Study of Femoral Nerve Block in Children With a Femur Fracture

March 28, 2018 updated by: Washington University School of Medicine

Examining the Efficacy of Femoral Nerve Block in Children With a Femoral Shaft Fracture

The purpose of this study is to examine the efficacy of the use of Marcaine in femoral nerve blocks and hematoma blocks for post operative pain relief for femoral shaft fractures in a pediatric population.

Study Overview

Status

Terminated

Intervention / Treatment

Detailed Description

Children with femur fractures can have severe pain after elastic nail fixation. The current national standard for post operative pain control would be intravenous narcotics. In addition to the use of intravenous narcotics, there are two alternative methods used during the surgery in order to potentially decrease the pain post-operatively. These methods are hematoma block or a femoral nerve block. Both are proven safe and effective in children, however little research has been done to look at the effectiveness of these various methods compared to one another.

Study Type

Interventional

Enrollment (Actual)

2

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Missouri
      • Saint Louis, Missouri, United States, 63110
        • Washington University
      • Saint Louis, Missouri, United States, 63110
        • St. Louis Childrens Hospital

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

7 years to 14 years (Child)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • A child with a femoral shaft fracture requiring surgical treatment and the placement of intramedullary nails
  • Weight of 30-100 Kg
  • Child must be older than 6 years old

Exclusion Criteria:

  • Any child that had an open fracture
  • A child that has a pain abnormality
  • Any child with an allergy to local anesthetic
  • Any child with a neurological injury
  • Any child with the inability to report pain
  • Any child that is unable to use a PCA post-operatively

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Triple

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
No Intervention: PCA only
this group will only get a pain control anesthesia pump to use for post-operative pain
Experimental: PCA and femoral nerve block
this group will be receiving a femoral nerve block during surgery and have a PCA post-operatively
0.75 cc/kg of 1/4% Marcaine
Other Names:
  • bupivacaine
Experimental: PCA + hematoma block
patient will receive hematoma block during surgery
0.75 cc/kg of 1/4% Marcaine
Other Names:
  • bupivacaine

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Post-operative Pain Scores
Time Frame: with in the first 24 hours

We will be looking at post-operative pain scores to see if those in the intervention group have lower pains scores.

Wong Baker FACES pain scale:The faces correspond to numeric values from 0-5. This scale can be documented with the numeric value. The pain scale goes from 0-5 with 0 being no pain and 5 being the worst pain.

0: No Hurt

  1. Hurts a little bit
  2. Hurts a little more
  3. Hurts even more
  4. Hurts a whole lot
  5. Hurts worst
with in the first 24 hours
Post-operative Narcotic Use
Time Frame: within first 24 horus
We will be looking at the amount of narcotics used after surgery to see if there is a reduction in narcotic use
within first 24 horus

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Femur Fracture Healing
Time Frame: first year
we will following patients to look at fracture healing post-operatively
first year

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: J. Eric Gordon, MD, Washington University School of Medicine

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

February 1, 2011

Primary Completion (Actual)

October 8, 2013

Study Completion (Actual)

October 8, 2014

Study Registration Dates

First Submitted

February 9, 2011

First Submitted That Met QC Criteria

February 9, 2011

First Posted (Estimate)

February 11, 2011

Study Record Updates

Last Update Posted (Actual)

March 30, 2018

Last Update Submitted That Met QC Criteria

March 28, 2018

Last Verified

March 1, 2018

More Information

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Pain, Postoperative

Clinical Trials on Marcaine

3
Subscribe